KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Change in Inventory (2016 - 2025)

AbbVie (ABBV) has disclosed Change in Inventory for 14 consecutive years, with $25.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 80.47% to $25.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $234.0 million, a 26.65% decrease, with the full-year FY2025 number at $234.0 million, down 26.65% from a year prior.
  • Change in Inventory was $25.0 million for Q4 2025 at AbbVie, up from -$2.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $385.0 million in Q1 2022 to a low of -$219.0 million in Q3 2021.
  • A 5-year average of $89.9 million and a median of $69.5 million in 2024 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: crashed 156.47% in 2023, then surged 233.33% in 2024.
  • AbbVie's Change in Inventory stood at $112.0 million in 2021, then soared by 51.79% to $170.0 million in 2022, then plummeted by 156.47% to -$96.0 million in 2023, then soared by 233.33% to $128.0 million in 2024, then tumbled by 80.47% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Change in Inventory are $25.0 million (Q4 2025), -$2.0 million (Q3 2025), and $56.0 million (Q2 2025).